HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Tiziana Life Sciences PLC (TLSA)
4.52  -0.07  (-1.53%) 08-13 01:52
Open: 4.57 High: 4.59
Pre.close: 4.59 Low: 4.33
Volume: 577,291 Ave vol: 1,216,764
52w High: 12.17 52w Low: 0.6162465
MA(50): 3.933 MA(200): 2.028
EPS: -0.136 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.tizianalifesciences.com
Market Cap (M): 473
Shares Out (M): 105
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. It also develops TZLS-501, a human anti-interleukin-6 receptor monoclonal antibody that is in pre-clinical development. The company was founded in 2013 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 10.01 Target 2: 14.21
Resist 1: 8.57 Resist 2: 12.17
Support 1: 2.74 Support 2: 2.28
Company key metrics
Revenue per Share: 0
Net Income per Share: 0
Cash per Share: 0
Book Value per Share: 0
Price to Sales: 0
Price to Book Value: 0
Earnings Yield: 0
Dividend Yield: 0
Debt to Equity: 0
Debt to Assets: 0
Financial analysis
Price to Book Value: Neutral
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Neutral
Price to Earnings: Neutral
Debt to Equity: Neutral
Stock Charts
Headline news
Tue, 11 Aug 2020
Tiziana Life Sciences to Present at BTIG's Virtual Biotechnology Conference - GlobeNewswire

Wed, 05 Aug 2020
Tiziana Life Sciences plc Announces Closing of $57.25 Million Offering - GlobeNewswire

Mon, 03 Aug 2020
Tiziana Life Sciences PLC (NASDAQ:TLSA) on the Path to Ruin - The Oracle Dispatch

Mon, 03 Aug 2020
Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million - GlobeNewswire

Fri, 31 Jul 2020
Tiziana Life Sciences plc: Total Voting Rights - GlobeNewswire

Thu, 30 Jul 2020
Tiziana Life Sciences to Participate in Investor Webinar to Provide Corporate Updates and Q&A Session on July 30, 2020 - GlobeNewswire

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.